Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1387.00
7.00 (0.51%)
< Home < Back

DR Reddy's Laboratories informs about press release

Date: 19-03-2024
DR Reddy's Laboratories has enclosed a Press Release on ‘Dr. Reddy's Laboratories launches Versavo (bevacizumab) in the UK’.

The above information is a part of company’s filings submitted to BSE.